Company intelligence / Profile preview

Guangzhou Baiji Shenzhou Biopharmaceutical

Guangzhou, Guangdong, Chinatians-group.com ↗

Ownership: Private
Development stage: Other

Overview

Guangzhou Baiji Shenzhou Biopharmaceutical operates GMP-compliant manufacturing facilities producing a range of biotherapeutics including adenoviral COVID vaccines, monoclonal antibodies, and gene therapies. The company has invested in large-scale production lines and quality control infrastructure to support both domestic and international demand for advanced biologics. Specific clinical results are not detailed in public sources.

Therapeutic areas: Infectious Diseases
Modalities: Adenovirus vector vaccine (COVID-19 vaccine)Monoclonal antibodyGene therapy (including lentivirus, adeno-associated virus, plasmid, oncolytic viruses)mRNA vaccine
Industry: Biotech

Beyond the preview

Go deeper on Guangzhou Baiji Shenzhou Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Baiji Shenzhou Biopharmaceutical.

Explore the full profile